Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Medivir AB
Medivir AB
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Medivir partners with GVK BIO to optimise R&D
Company reorganises its discovery and research operations and focuses on key areas of oncology and infectious diseases
Research & Development
Medivir and Cancer Research Technology link up to develop new cancer drugs
Will conduct a two-year research programme to develop small molecules targeting the ADAM8 protein
Research & Development
Medivir makes changes to management team
To create a smaller and more effective team with fewer functions
Research & Development
Medivir to develop new drugs for bacterial infections
Swedish University of Agricultural Sciences will receive a fee for research services
Medivir hires head of commercial activities
Henric Juserius joins the Swedish firm in August
Research & Development
Medivir signs dengue virus deal with Janssen
Strengthens presence in infectious diseases
Research & Development
Medivir appoints vp for r&d projects
Charlotte Edenius takes up newly created position
Subscribe now